Bioinvent Ab

(BOVNF)

By |

Profile

BioInvent International AB is engaged in developing antibody-based drugs to treat haematological cancers, as well as therapies, by affecting normal blood cells. The Company\'s product include; BI-505, BI-1206, n-CoDeR, F.I.R.S.T. and TB-403.

Contact Information

Website: www.bioinvent.com
Main Phone: +46 462868550
Address: Solvegatan 41
City / Town: Lund
Country: SWE
Postal Code: 223 70

Issuer Information

Exchange: GREY
Employees: 43
$ 0.21 $ 0.00 (0.00%)
Last Price 0.22 Change $ 0.00 Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.22
Last Trade Volume 0 52 Wk Hi 0.38 52 Wk Low 0.22
Market Cap 60.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 282,721,619.00 EPS (TTM) -0.03 PE Ratio N/A Exchange Greys

News